跳至主要内容
临床试验/JPRN-UMIN000031422
JPRN-UMIN000031422已完成未知

SNP analysis of brexpiprazole-treated Japanese schizophrenia patients. - Genomics analysis-schizophrenia

Otsuka Pharmaceutical Co., Ltd.0 个研究点目标入组 280 人开始时间: 2018年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
18years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Female patients who are breastfeeding or who have a positive pregnancy test (urine) result prior to receiving investigational medicinal product -Patients presenting a first episode of schizophrenia based on the clinical judgement of the investigator -Patients who are diagnosed with a disease other than schizophrenia (schizoaffective disorder, major depressive disorder, bipolar disorder, posttraumatic stress disorder, anxiety disorder, delirium, dementia, amnesia, or other cognitive disorder) based on current DSM-IV-TR Axis I criteria, or who are diagnosed with a personality disorder (borderline, paranoid, histrionic, schizotypal, schizoid, or antisocial)

研究者

相似试验